Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 3123599Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$1.9M
Full award amounts, FY2024
Award Records
4
Records listing this PI
Award-Linked Rank
#6,032
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Qing Yi as a PI. Multi-PI records show the full award amount for context.
- 1R01CA285209-01R01Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors$489.9Kaward amount
- 1R01CA285203-01A1R01Exploring the role and potential of anti-viral drugs to sensitize cancer cells to chemotherapy$472.4Kaward amount
- 5R01CA278787-02R01Role of lipid metabolism in CD8+ T cell ferroptosis$460.3Kaward amount
- 5R01CA282099-02R01Novel mechanism of induction of tumor pyroptosis by IL-9-secreting Tc9 cells$449.6Kaward amount
Award organization
Organizations that administered FY2024 awards listing Qing Yi as a PI.
FY2024 award administered by Houston Methodist Research Institute (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardHouston Methodist Research Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #6032
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding